Zobrazeno 1 - 10
of 465
pro vyhledávání: '"V I, PETROV"'
Publikováno v:
Безопасность и риск фармакотерапии, Vol 12, Iss 3, Pp 268-284 (2024)
INTRODUCTION. The risk of liver damage correlates with the severity of COVID-19. However, a growing number of studies have shown an association between liver function impairment and combinations of medicinal products used to treat COVID-19.AIM. The s
Externí odkaz:
https://doaj.org/article/908bb8ced2e34e8b9a371822385ab873
Publikováno v:
Фармакоэкономика, Vol 17, Iss 1, Pp 62-75 (2024)
Background. The study of drug availability for patients with chronic obstructive pulmonary disease (COPD) represents one of the priority tasks in the organization of effective counteraction to COPD in the Russian Federation.Objective: to assess drug
Externí odkaz:
https://doaj.org/article/8dea04a7a87e40a0aad435b7f0c54e3e
Publikováno v:
Фармация и фармакология (Пятигорск), Vol 12, Iss 1, Pp 4-14 (2024)
The aim of the work was to compare the effects of ademethionine, acetylcysteine and taurine on the zoosocial behavior of rats in a post-intoxicated state after an acute ethanol poisoning.Materials and methods. The study was conducted on male rats of
Externí odkaz:
https://doaj.org/article/5c43ef2c5c9d4fd587a53a72f20a3df8
Autor:
V. I. Petrov
Publikováno v:
Реальная клиническая практика: данные и доказательства, Vol 4, Iss 1, Pp 66-68 (2024)
The European SocIn March 2024, the manual “Clinical and pharmacological characteristics of biotechnological drugs: from classifications to adverse events” was published under general ed. Kolbin A. S. This textbook discusses biotechnological drugs
Externí odkaz:
https://doaj.org/article/11acbafa878847d88e3652b761bfe74c
Autor:
D. V. Kurkin, E. I. Morkovin, D. A. Bakulin, A. V. Zaborovsky, I. E. Makarenko, R. V. Drai, A. G. Solodovnikov, V. I. Petrov, K. N. Koryanova, N. A. Lycheva, S. A. Voskresensky, A. V. Strygin, Yu. A. Kolosov, Yu. V. Gorbunova, O. V. Ivanova
Publikováno v:
Фармация и фармакология (Пятигорск), Vol 11, Iss 5, Pp 384-398 (2024)
The aim of the work was to conduct an analysis of the current state and current trends in the approval of drugs, as well as some aspects of the methodology for their development based on biological molecules and registration.Materials and methods. Th
Externí odkaz:
https://doaj.org/article/2dc8114950e748bbbd40243f3b14fe6b
Autor:
D. V. Kurkin, D. A. Bakulin, E. I. Morkovin, V. I. Petrov, A. V. Strygin, K. N. Koryanova, Yu. V. Gorbunova, Yu. A. Kolosov, O. V. Ivanova, E. V. Pavlova, M. A. Dzhavakhyan, A. V. Zaborovsky, V. B. Saparova, I. E. Makarenko, R. I. Drai, A. N. Chumachenko
Publikováno v:
Фармация и фармакология (Пятигорск), Vol 11, Iss 4, Pp 347-380 (2024)
Modern approaches to the treatment of type 2 diabetes mellitus (T2DM) are aimed not only at glycemic control, but also at reducing cardiovascular risks. The increasing prevalence of the disease and the need for effective treatment options highlight t
Externí odkaz:
https://doaj.org/article/95f6d86f77b4438484e0b9ff432b4ee0
Publikováno v:
Фармация и фармакология (Пятигорск), Vol 11, Iss 4, Pp 280-290 (2024)
Therapeutic drug monitoring (TDM) is used to increase the individualization of pharmacotherapy, especially in patient groups with a high interindividual variability in pharmacokinetic (PK) parameters. One of these groups of patients is newborn childr
Externí odkaz:
https://doaj.org/article/ca68963d8b8f45b89606e67601361cde
Autor:
D. V. Kurkin, E. I. Morkovin, D. A. Bakulin, Yu. V. Gorbunova, Yu. A. Kolosov, M. A. Dzhavakhyan, I. E. Makarenko, R. V. Drai, A. V. Zaborovsky, O. V. Shatalova, A. V. Strygin, V. I. Petrov, A. P. Pleten, A. A. Prokopov, T. Yu. Tatarenko-Kozmina
Publikováno v:
Фармация и фармакология (Пятигорск), Vol 11, Iss 3, Pp 193-210 (2023)
The aim of the work is to conduct a review of medications approved by the FDA in 2022.Materials and methods. In searching for the materials to write this review article, bibliographic databases including PubMed, Google Scholar and e-library.ru were u
Externí odkaz:
https://doaj.org/article/8583ca5a7d4043de9ab1b0dd5ccb0858
Autor:
D. V. Kurkin, D. A. Bakulin, E. I. Morkovin, A. V. Strygin, Yu. V. Gorbunova, E. V. Volotova, I. E. Makarenko, V. B. Saparova, R. V. Drai, V. I. Petrov
Publikováno v:
Фармация и фармакология (Пятигорск), Vol 11, Iss 1, Pp 19-47 (2023)
Modern requirements for the treatment of type 2 diabetes mellitus (DM2) include not only achieving a glycemic control, but also reducing the risk of developing cardiovascular complications. Dipeptidyl peptidase 4 (DPP-4) inhibitors are inferior in th
Externí odkaz:
https://doaj.org/article/f0fe50a3b67f4dd0bc0505b700df9935
Safety of Using Contrast Agents in Coronary Angiography in a Multidisciplinary Hospital in Volgograd
Autor:
V. I. Petrov, A. A. Kudasheva
Publikováno v:
Безопасность и риск фармакотерапии, Vol 11, Iss 1, Pp 97-104 (2023)
Contrast-induced nephropathy (CIN) is a serious adverse reaction to contrast agents used in radiography. It is important to study the epidemiology of CIN and the risk factors for developing the complication in order to improve the quality of care tha
Externí odkaz:
https://doaj.org/article/d5606b3895d249c8ae7f965b5071c63e